Gen Synthesis of Receptor Binding Protein (RBP) of Nipah Virus

Gen Synthesis of receptor binding protein (RBP) of Nipah Virus,Expression of RBP in mammalian gene

Tender Timeline

Tender Issue
May 21, 2025 at 2:24 PM

Tender Title: Gen Synthesis of Receptor Binding Protein (RBP) of Nipah Virus

Reference Number: 47765eecf

Issuing Authority/Department

The tender is issued by the Department of Defence Research & Development, under the auspices of the Ministry of Defence.

Scope of Work and Objectives

The primary objective of this tender is to secure the services and products related to the general synthesis of receptor binding protein (RBP) of the Nipah Virus. Bidders are required to provide comprehensive solutions which encompass the expression of RBP in mammalian gene expression systems, as well as its subsequent purification. In addition, the tender involves the production and purification of monoclonal antibodies against the RBP of the Nipah Virus. The overarching goal is to advance research and development efforts aimed at addressing the threats posed by this viral pathogen.

Eligibility Criteria

To qualify for participation in this tender, bidders must meet specific eligibility criteria including, but not limited to:

  • Registration as a legal entity with the relevant statutory bodies.
  • Proven experience in biotechnological applications specifically relating to protein synthesis.
  • Prior successful execution of similar projects, preferably within the health or defence sectors.

Technical Requirements

Participants must fulfill various technical requirements including:

  • Capability to execute complex protein synthesis tasks.
  • Utilization of mammalian gene expression systems.
  • An established protocol for the purification of proteins.
  • Proficiency in producing and purifying monoclonal antibodies tailored for the Nipah Virus.

Financial Requirements

Bidders should demonstrate financial viability through the submission of:

  • Audited financial statements from the last three financial years.
  • Proof of the capability to finance the tender requirements and intricacies involved in the production and synthesis processes.

Document Submission Details

All proposals must be submitted in accordance with the instructions laid out in the tender documentation. Submission of documents must adhere to stipulated formats and must be comprehensive to ensure evaluation efficiency.

Special Provisions

Consideration will be extended to Micro, Small, and Medium Enterprises (MSEs) and startups who fulfill the eligibility criteria. These entities may benefit from relaxed requirements to encourage their participation.

Evaluation Process

The evaluation of the tenders will be carried out rigorously based on:

  • Compliance with the eligibility and technical criteria.
  • Financial capability as validated through supporting documentation.
  • Innovation and methodology proposed in the synthesis and purification processes.

Delivery Locations

Products and services rendered will be delivered to specified locations as outlined in the successful bidder's proposal.

Contact Information

For inquiries and further clarifications, bidders are encouraged to reach out to the issuing department via the communication channels specified in the tender documentation.


General Information

Item Category
Gen Synthesis of receptor binding protein (RBP) of Nipah Virus , Expression of RBP in mammalian gene expression system and its purification , Monoclonal antibody production & Purification against RBP of Nipah Virus
Ministry Name

Financial Information

Bid Offer Validity
90 (Days)
Arbitration Clause
No
Mediation Clause
No

Evaluation and Technical Information

Evaluation Method
Total value wise evaluation
RA Qualification Rule
H1-Highest Priced Bid Elimination
Inspection Required
Yes
Technical Clarifications Time
2 Days

Tender Documents

6 Documents
GeM-Bidding-7869305.pdfMain Document
Other DocumentsOTHER
Other DocumentsOTHER
Other DocumentsOTHER
Buyer uploaded ATC documentATC ATC
GEM General Terms and Conditions DocumentGEM_GENERAL_TERMS_AND_CONDITIONS

Frequently Asked Questions

The eligibility requirements include being a registered entity that has the capability to conduct sophisticated biotechnological applications. Bidders must demonstrate proven experience in protein synthesis and must have successfully completed similar projects in the past, particularly in sectors related to health or defence.

Technical specifications stipulate that participants must successfully execute protein synthesis using mammalian gene expression systems. Additionally, there is a need for proficiency in the purification of proteins and the ability to produce and purify monoclonal antibodies specifically against the Nipah Virus.

Details regarding the Earnest Money Deposit (EMD) and performance security are typically specified in the tender documentation. Bidders often need to provide an EMD as a commitment to their proposal and may require a performance security upon awarding of the contract. It is crucial to refer to the tender document for these precise figures and requirements.

Proposals must be submitted according to the specific submission details outlined in the tender documentation. Typically, this would involve electronic submission formats and adherence to specified content and structure requirements to ensure a successful evaluation process.

Yes, there are special provisions that favor MSEs and startups in this tender process. These entities may benefit from relaxed eligibility criteria and related conditions to enhance their participation and enable them to contribute effectively to the project. Compliance with Make in India policies and local procurement rules will also be considered to promote local sourcing.

Probable Bidders

Companies likely to bid

Get Tender Alerts

Get notifications for similar tenders